Sarissa Capital Management LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sarissa Capital Management LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$157,835,700
-9.5%
16,390,0000.0%21.26%
+22.5%
Q2 2023$174,389,600
+1.1%
16,390,0000.0%17.36%
-21.3%
Q1 2023$172,422,800
-15.1%
16,390,0000.0%22.05%
-8.8%
Q4 2022$203,072,100
+19.6%
16,390,0000.0%24.17%
+25.9%
Q3 2022$169,800,000
-10.1%
16,390,0000.0%19.19%
+0.9%
Q2 2022$188,977,000
-8.3%
16,390,0000.0%19.02%
-2.4%
Q1 2022$206,186,000
+7.9%
16,390,0000.0%19.49%
+17.8%
Q4 2021$191,107,000
-10.7%
16,390,0000.0%16.54%
-1.5%
Q3 2021$214,053,000
+1.5%
16,390,0000.0%16.80%
+0.2%
Q2 2021$210,939,000
+15.1%
16,390,0000.0%16.77%
-4.5%
Q1 2021$183,240,000
+14.6%
16,390,000
+16.7%
17.56%
+7.6%
Q4 2020$159,915,000
+26.6%
14,040,0000.0%16.32%
+9.8%
Q3 2020$126,289,000
-12.8%
14,040,0000.0%14.87%
-7.8%
Q2 2020$144,892,000
+6.2%
14,040,000
+3.8%
16.12%
-7.4%
Q1 2020$136,467,000
-0.5%
13,525,000
+31.2%
17.41%
+52.9%
Q4 2019$137,186,000
+58.2%
10,307,000
+2.0%
11.39%
+4.8%
Q3 2019$86,734,000
-18.4%
10,103,000
+4.0%
10.87%
-18.0%
Q2 2019$106,314,000
+4.2%
9,718,000
+28.8%
13.25%
-13.7%
Q1 2019$102,045,000
+57.5%
7,542,200
+20.6%
15.36%
+7.0%
Q4 2018$64,773,000
+4.2%
6,252,300
+85.7%
14.35%
+4.7%
Q3 2018$62,156,000
-3.5%
3,367,1000.0%13.71%
+6.2%
Q2 2018$64,378,000
+23.9%
3,367,1000.0%12.91%
+7.4%
Q1 2018$51,954,000
+110.1%
3,367,100
+104.1%
12.02%
+89.9%
Q4 2017$24,733,0001,650,0006.33%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders